Alessia David

ORCID: 0000-0001-9449-1303
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Biochemical and Molecular Research
  • Neuroendocrine Tumor Research Advances
  • ATP Synthase and ATPases Research
  • Adrenal and Paraganglionic Tumors
  • Nanoparticle-Based Drug Delivery
  • Pituitary Gland Disorders and Treatments
  • Growth Hormone and Insulin-like Growth Factors

Imperial College London
2025

Abstract Objective Heterozygous germline loss-of-function variants in AIP are associated with young-onset growth hormone and/or prolactin-secreting pituitary tumours. However, the pathogenic role of c.911G>A; p.(Arg304Gln) (R304Q) variant has been controversial. Recent data from public exome/genome databases show this is not infrequent. The objective work was to reassess pathogenicity R304Q based on clinical, genomic and functional assay data. Design, materials methods Data were...

10.1093/ejendo/lvaf044 article EN cc-by-nc European Journal of Endocrinology 2025-03-12

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)

10.1530/endoabs.44.p27 article EN Endocrine Abstracts 2016-10-14
Coming Soon ...